The Net Margin of Prelude Therapeutics Incorporated (PRLD) is
-819.59%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
| Date |
Value |
| 2025-12-31 |
-819.59%
|
| 2024-12-31 |
-1816.76%
|
| Ticker |
Name |
Value |
|
ABBV
|
AbbVie Inc.
|
6.91%
|
|
DMTK
|
DermTech Inc
|
-659.57%
|
|
SWTX
|
SpringWorks Therapeutics, Inc.
|
-134.73%
|
|
950160.KQ
|
Kolon TissueGene Inc
|
-3733.25%
|
|
950200.KQ
|
Psomagen Inc
|
-5.04%
|
|
ADCT
|
Adc Therapeutics Ltd
|
-175.31%
|
|
KURA
|
Kura Oncology, Inc.
|
-412.95%
|
|
MRNA
|
Moderna, Inc.
|
-145.16%
|
|
NRIX
|
Nurix Therapeutics, Inc.
|
-314.90%
|
|
950220.KQ
|
Neoimmunetech Inc
|
-33533.01%
|
|
DCPH
|
Deciphera Pharmaceuticals Inc
|
-119.34%
|
|
GBIO
|
Generation Bio Co
|
-661.91%
|
|
GILD
|
Gilead Sciences, Inc.
|
28.90%
|
|
VIE
|
Viela Bio Inc
|
-1293.07%
|
|
KYMR
|
Kymera Therapeutics, Inc.
|
-794.04%
|
|
AMGN
|
Amgen Inc
|
20.98%
|
|
CGEM
|
Cullinan Therapeutics, Inc.
|
-346.20%
|
|
IMCR
|
Immunocore Holdings PLC
|
-8.88%
|
|
INO
|
Inovio Pharmaceuticals Inc
|
-130005.97%
|
|
IGMS
|
IGM Biosciences LLC
|
-7316.16%
|
|
ALVR
|
Allovir Inc
|
-14023.53%
|
|
ALXO
|
ALX Oncology Holdings Inc
|
-3876.27%
|
|
BCAB
|
Bioatla Inc
|
-2980.35%
|
|
RCUS
|
Arcus Biosciences, Inc.
|
-142.91%
|
|
LGND
|
Ligand Pharmaceuticals Incorporated
|
46.42%
|
|
REGN
|
Regeneron Pharmaceuticals, Inc.
|
31.41%
|
|
VRTX
|
Vertex Pharmaceuticals Incorporated
|
32.94%
|
|
FGEN
|
FibroGen Inc
|
-160.63%
|
|
GBT
|
Global Blood Therapeutics Inc
|
-155.63%
|
|
MCRB
|
Seres Therapeutics, Inc.
|
721.93%
|
|
MYOV
|
Myovant Sciences Ltd
|
-89.18%
|